Novo Nordisk Research Center, Lexington, Massachusetts, United StatesLexington, Massachusetts, United States
Disclosure information not submitted.
SUN-677 - Β₁-Adrenergic Blockade Preserves the Metabolic Benefits of Β₃-Adrenergic Agonism without Raising Blood Pressure
Sunday, June 14, 20269:00 AM - 4:00 PM CT